Immunohistochemistry‐based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy

Immunohistochemistry‐based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy

Abstract Distinct molecular subtypes of muscle‐invasive bladder cancer (MIBC) may show different platinum sensitivities. Currently available data were mostly generated at transcriptome level and have limited comparability to each other. We aimed to determine the platinum sensitivity of molecular sub...

Full description

Saved in:
Bibliographic Details
Main Authors: Csilla Olah, Oleksandr Shmorhun, Gilbert Georg Klamminger, Josefine Rawitzer, Lara Sichward, Boris Hadaschik, Mulham Al‐Nader, Ulrich Krafft, Christian Niedworok, Melinda Váradi, Peter Nyirady, Andras Kiss, Eszter Szekely, Henning Reis, Tibor Szarvas
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:The Journal of Pathology: Clinical Research
Subjects:
bladder cancer
molecular subtype classification
cisplatin
chemotherapy
immunohistochemistry
Lund Taxonomy
Online Access:https://doi.org/10.1002/2056-4538.70017
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/2056-4538.70017

Similar Items